Mark Kriegsmann

6.0k total citations
181 papers, 3.0k citations indexed

About

Mark Kriegsmann is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Mark Kriegsmann has authored 181 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Oncology, 60 papers in Pulmonary and Respiratory Medicine and 54 papers in Molecular Biology. Recurrent topics in Mark Kriegsmann's work include Lung Cancer Treatments and Mutations (34 papers), Advanced Proteomics Techniques and Applications (26 papers) and Mass Spectrometry Techniques and Applications (25 papers). Mark Kriegsmann is often cited by papers focused on Lung Cancer Treatments and Mutations (34 papers), Advanced Proteomics Techniques and Applications (26 papers) and Mass Spectrometry Techniques and Applications (25 papers). Mark Kriegsmann collaborates with scholars based in Germany, United States and Austria. Mark Kriegsmann's co-authors include Jörg Kriegsmann, Rita Casadonte, Katharina Kriegsmann, Wilko Weichert, Rémi Longuespée, Albrecht Stenzinger, Thomas Muley, Arne Warth, Kristina Schwamborn and Daniel Kazdal and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Blood.

In The Last Decade

Mark Kriegsmann

170 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Kriegsmann Germany 32 1.3k 938 779 545 529 181 3.0k
Jörg Kriegsmann Germany 33 1.4k 1.1× 588 0.6× 640 0.8× 362 0.7× 361 0.7× 116 3.5k
Kazufumi Honda Japan 38 2.3k 1.9× 1.2k 1.3× 472 0.6× 619 1.1× 795 1.5× 116 4.2k
Claudio Belluco Italy 30 1.1k 0.9× 1.1k 1.2× 376 0.5× 542 1.0× 407 0.8× 79 3.0k
Valerie Calvert United States 30 2.6k 2.1× 546 0.6× 711 0.9× 266 0.5× 540 1.0× 59 3.7k
Horst Zitzelsberger Germany 41 2.6k 2.0× 990 1.1× 604 0.8× 591 1.1× 1.3k 2.5× 141 4.9k
Qing Kay Li United States 28 1.3k 1.1× 1.3k 1.4× 187 0.2× 1.2k 2.2× 580 1.1× 76 3.1k
Rémi Longuespée Germany 27 1.4k 1.1× 427 0.5× 1.1k 1.4× 316 0.6× 395 0.7× 78 2.4k
J. Alex United States 18 1.0k 0.8× 456 0.5× 498 0.6× 750 1.4× 885 1.7× 42 2.4k
Fabio Pagni Italy 28 556 0.4× 594 0.6× 329 0.4× 508 0.9× 301 0.6× 184 2.4k
Michaela Aubele Germany 30 1.8k 1.4× 746 0.8× 618 0.8× 356 0.7× 876 1.7× 85 3.1k

Countries citing papers authored by Mark Kriegsmann

Since Specialization
Citations

This map shows the geographic impact of Mark Kriegsmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Kriegsmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Kriegsmann more than expected).

Fields of papers citing papers by Mark Kriegsmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Kriegsmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Kriegsmann. The network helps show where Mark Kriegsmann may publish in the future.

Co-authorship network of co-authors of Mark Kriegsmann

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Kriegsmann. A scholar is included among the top collaborators of Mark Kriegsmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Kriegsmann. Mark Kriegsmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
März, Keno, Sebastian Bodenstedt, Felix Nickel, et al.. (2024). Aliado - A design concept of AI for decision support in oncological liver surgery. European Journal of Surgical Oncology. 51(7). 108669–108669. 2 indexed citations
2.
Alhamwe, Bilal Alashkar, Frederik Trinkmann, Mark Kriegsmann, et al.. (2024). Peripheral Inflammation Featuring Eosinophilia or Neutrophilia Is Associated with the Survival and Infiltration of Eosinophils within the Tumor among Various Histological Subgroups of Patients with NSCLC. International Journal of Molecular Sciences. 25(17). 9552–9552. 1 indexed citations
3.
Casadonte, Rita, Mark Kriegsmann, Katharina Kriegsmann, et al.. (2023). Imaging Mass Spectrometry for the Classification of Melanoma Based on BRAF/NRAS Mutational Status. International Journal of Molecular Sciences. 24(6). 5110–5110. 3 indexed citations
4.
Muley, Thomas, Michael Meister, Michael Thomas, et al.. (2023). CYFRA 21-1, CA 125 and CEA provide additional prognostic value in NSCLC patients with stable disease at first CT scan. Tumor Biology. 46(s1). S163–S175. 1 indexed citations
5.
Muley, Thomas, Felix Herth, Claus Peter Heußel, et al.. (2023). Prognostic value of tumor markers ProGRP, NSE and CYFRA 21-1 in patients with small cell lung cancer and chemotherapy-induced remission. Tumor Biology. 46(s1). S219–S232. 8 indexed citations
6.
Hellmich, Bernhard, et al.. (2023). Interstitielle Lungenerkrankungen. PubMed Central. 20(4). 222–233.
7.
Bruch, Peter‐Martin, Carolin Kolb, Sophie A. Herbst, et al.. (2022). Drug‐microenvironment perturbations reveal resistance mechanisms and prognostic subgroups in CLL. Molecular Systems Biology. 18(8). e10855–e10855. 10 indexed citations
8.
Trefzer, Timo B., Marc A. Schneider, Katharina Jechow, et al.. (2022). Intratumoral Heterogeneity and Immune Modulation in Lung Adenocarcinoma in Female Smokers and Never Smokers. Cancer Research. 82(17). 3116–3129. 4 indexed citations
9.
Sirinian, Chaido, Özge Karayel, Søren E. Degn, et al.. (2022). Analysis of RANK-c interaction partners identifies TRAF3 as a critical regulator of breast cancer aggressiveness. Neoplasia. 33. 100836–100836. 1 indexed citations
10.
Schneider, Marc A., Mark Kriegsmann, H. Winter, et al.. (2022). Lung Adenocarcinoma Cell Sensitivity to Chemotherapies: A Spotlight on Lipid Droplets and SREBF1 Gene. Cancers. 14(18). 4454–4454. 1 indexed citations
11.
Baum, Philip, Thomas Muley, Mark Kriegsmann, et al.. (2021). Validation of the T Descriptor (TNM-8) in T3N0 Non-Small-Cell Lung Cancer Patients; a Bicentric Cohort Analysis with Arguments for Redefinition. Cancers. 13(8). 1812–1812. 1 indexed citations
12.
Roupakia, Eugenia, Georgia Karpathiou, Giannis Vatsellas, et al.. (2021). Canonical NF-κB Promotes Lung Epithelial Cell Tumour Growth by Downregulating the Metastasis Suppressor CD82 and Enhancing Epithelial-to-Mesenchymal Cell Transition. Cancers. 13(17). 4302–4302. 2 indexed citations
13.
Turkowski, Kati, Stefan Günther, Andreas Weigert, et al.. (2021). Interferon Regulatory Factor 9 Promotes Lung Cancer Progression via Regulation of Versican. Cancers. 13(2). 208–208. 15 indexed citations
14.
Eichhorn, Florian, Laura V. Klotz, Mark Kriegsmann, et al.. (2021). Neoadjuvant anti-programmed death-1 immunotherapy by pembrolizumab in resectable non-small cell lung cancer: First clinical experience. Lung Cancer. 153. 150–157. 61 indexed citations
15.
Medeiros, Rui, María José Oliveira, Carlos Robalo Cordeiro, et al.. (2020). Germline Genetic Variants of the Renin-Angiotensin System, Hypoxia and Angiogenesis in Non-Small Cell Lung Cancer Progression: Discovery and Validation Studies. Cancers. 12(12). 3834–3834. 1 indexed citations
16.
Rosenbaum, Marc, Andreas Gewies, Konstanze Pechloff, et al.. (2019). Bcl10-controlled Malt1 paracaspase activity is key for the immune suppressive function of regulatory T cells. Nature Communications. 10(1). 2352–2352. 60 indexed citations
17.
Kriegsmann, Mark, Disorn Sookthai, Renée T. Fortner, et al.. (2018). Obesity as risk factor for subtypes of breast cancer: results from a prospective cohort study. BMC Cancer. 18(1). 616–616. 53 indexed citations
18.
Adler, D., Mark Kriegsmann, Hans‐Peter Sinn, et al.. (2018). Spinale Mammakarzinommetastasen aus Sicht der Wirbelsäulenchirurgie: Prädiktoren auf Molekularebene zur Wahl der adäquaten Therapiestrategie. Der Orthopäde. 47(7). 594–603.
19.
Leichsenring, Jonas, Anna‐Lena Volckmar, Martina Kirchner, et al.. (2017). Targeted deep sequencing of effusion cytology samples is feasible, informs spatiotemporal tumor evolution, and has clinical and diagnostic utility. Genes Chromosomes and Cancer. 57(2). 70–79. 13 indexed citations
20.
Lisenko, Katharina, Martin Cremer, Mark Kriegsmann, et al.. (2016). Efficient stem cell collection after modified cisplatin-based mobilization chemotherapy in patients with DLBCL. Oncology Research and Treatment. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jörg Kriegsmann Breakdown of academic impact, for papers by Kazufumi Honda Breakdown of academic impact, for papers by Claudio Belluco Breakdown of academic impact, for papers by Valerie Calvert Breakdown of academic impact, for papers by Horst Zitzelsberger Breakdown of academic impact, for papers by Qing Kay Li Breakdown of academic impact, for papers by Rémi Longuespée Breakdown of academic impact, for papers by J. Alex Breakdown of academic impact, for papers by Fabio Pagni Breakdown of academic impact, for papers by Michaela Aubele
Rankless by CCL
2026